NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE216986 Query DataSets for GSE216986
Status Public on Aug 07, 2023
Title Decitabine treatment reveals a functional role of DNA hypomethylation in organising enhancer-promoter interactions [EPIC]
Organism Homo sapiens
Experiment type Methylation profiling by genome tiling array
Summary DNA methylation is one of the most important epigenetic marks and changes in DNA methylation patterns have been associated with many different types of cancer. Recently, three-dimensional (3D) genome organisation has been demonstrated to play a fundamental role in gene regulation. Determining the interplay between DNA methylation and 3D chromatin structure and function is challenging due to the extreme complexity of epigenetic regulation. To study the impact of DNA methylation on 3D genome organization, we performed a time-course of Decitabine treatment in tamoxifen-resistant MCF7 (TAMR) cells. Decitabine was applied daily for 7 days, followed by “recovery” up to 28 days and DNA methylation (EPIC), gene expression (RNA-seq) and promoter-enhancer interactions (PCHi-C) were assessed on day 7 post-Decitabine- and Vehicle-treatment and day 28 “Recovery” and Vehicle treatment in duplicate. Our data revealed a functional link between DNA hypomethylation at distal enhancer regions, enhancer-promoter interactions, and gene regulation.
 
Overall design To understand the role of Decitabine-induced DNA hypomethylation on 3D genome organisation, we used in situ Promoter Capture Hi-C to generate promoter-centric 3D genome maps of TAMR cells treated with Decitabine for 7 days and following 21 days of “recovery”. At the same time, we examined the genome-wide DNA methylation (EPIC Microarrays) and gene expression (RNA-seq) in the same samples.
 
Contributor(s) Achinger-Kawecka J
Citation(s) 38448820
Submission date Nov 01, 2022
Last update date Mar 13, 2024
Contact name Joanna Achinger-Kawecka
E-mail(s) [email protected]
Organization name South Australian Immunogenomics Cancer Institute
Street address AHMS Building, North Terrace
City Adelaide
State/province SA
ZIP/Postal code 5005
Country Australia
 
Platforms (1)
GPL21145 Infinium MethylationEPIC
Samples (8)
GSM6701736 TAMR Control Early 1 [EPIC]
GSM6701737 TAMR Control Early 2 [EPIC]
GSM6701738 TAMR Decitabine Day 7 1 [EPIC]
This SubSeries is part of SuperSeries:
GSE216989 Decitabine treatment reveals a functional role of DNA hypomethylation in organising enhancer-promoter interactions
Relations
BioProject PRJNA896534

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE216986_Matrix_processed_TamR_AZA.tsv.gz 70.7 Mb (ftp)(http) TSV
GSE216986_RAW.tar 272.6 Mb (http)(custom) TAR (of IDAT)
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap